Public database analyses revealed that high expression of CD81 protein in breast tumors was associated with an unfavorable overall survival, relapse-free survival, and distant metastasis-free survival in patients with TNBC (Liu_2014 cohort) (Osz et al., 2021; Figure 4A–C, Figure 4—figure supplement 1). The gene discussed is CD81; the disease is breast neoplasm.